Japan generic distribution system set for shake-up
This article was originally published in Scrip
Executive Summary
Japan's steadily growing generic drug sector could receive a new boost from the entry of the country's largest general delivery firm, which is promising to address some of the distribution cost, efficiency and reliability issues which have held back the wider adoption of such products.